Chapter 10. Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial

American Journal of Clinical Nutrition

Volumn 65, Issue 1 SUPPL., 1997, Pages

  Tillotson, Jeanne L ^b   Grandits, Gregory A ^a   Bartsch, Glenn E ^b   Stamler, Jeremiah ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

blood lipids; Carbohydrate intake; starch; sucrose

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; CARBOHYDRATE; CHOLESTEROL; FRUCTOSE; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALTOSE; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STARCH; SUCROSE; SUGAR;

ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CARBOHYDRATE INTAKE; CIGARETTE SMOKING; CLINICAL TRIAL; DIET; ENERGY; HUMAN; LIPID BLOOD LEVEL; MALE; RISK FACTOR; TYPES OF STUDY; CARBOHYDRATE DIET; DIETARY FIBER;

DIETARY CARBOHYDRATES; DIETARY FIBER; HUMANS; LIPIDS; MALE; RISK FACTORS;

EID: 0030635507     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Tillotson JL, Grandits GA, Bartsch GE, Stamler J. Chapter 11. Relation of dietary fiber to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. In: Stamler J, Caggiula AW, Cutler JA et al, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997;65(suppl):327S-37S.
2. Dolecek TA, Stamler J, Caggiula AW, Tillotson JL, Buzzard IM. Chapter 3. Methods of dietary and nutritional assessment and intervention and other methods in the Multiple Risk Factor Intervention Trial. In: Stamler J, Caggiula AW, Cutler JA et al, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997;65(suppl):196S-210S.
3. Gorder DD, Bartsch GE, Tillotson JL, Stamler J, Chapter 6. Food group and macronutrient intakes, trial years 1-6. in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. In: Stamler J, Caggiula AW, Cutler JA et al, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997;65(suppl):258S-71S.
4. Grandits GA, Bartsch GE, Stamler J. Chapter 4. Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial. In: Stamler J, Caggiula AW, Cutler JA et al, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997;65(suppl):211S-27S.
5. Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med 1986;15:254-73.
6. McGandy RB, Hegsted DM, Myers ML, Stare RJ. Dietary carbohydrate and serum cholesterol levels in man. Am J Clin Nutr 1966;18:237-42.
7. Little JA, Birchwood BL, Simmons DA, et al. Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 1. Sucrose and starch with polyunsaturated fat. Atherosclerosis 1970;11:173-81.
8. Birchwood BL, Little JA, Antar MA, et al. Interrelationsip between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 2. Sucrose and starch with mixed saturated and polyunsaturated fats. Atherosclerosis 1970;11:183-90.
9. Antar MA, Little JA, Lucas C, Buckley GC, Csima A. Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 3. Synergistic effect of sucrose and animal fat on serum lipids. Atherosclerosis 1970;11:191-201.
10. Grande F, Anderson JT, Keys A. Effect of carbohydrates of leguminous seeds, wheat and potatoes on serum cholesterol concentration in man. J Nutr 1965;86:313-7.
11. Ahrens EH, Hirsch J, Oette K, Farquhar JW, Stein Y. Carbohydrate-induced and fat-induced lipemia. Trans Assoc Am Physicians 1961;74:134-46.
12. Antonis A, Bersohn I. The influence of diet on serum triglycerides in South Africa white Bantu prisoners. Lancet 1961;1:3-9.
13. Katz LN, Stamler J, Pick R. Nutrition and atherosclerosis. Philadelphia: Lea and Febiger, 1958.
14. Stamler J. Lectures on preventive cardiology. New York: Grune and Stratton, 1967.
15. National Diet Heart Study Research Group. National Diet Heart Study final report. Circulation 1968;37:1(suppl):I1-428.
16. Wilson WS, Hulley SB, Burrows MI, Nichaman MZ. Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet. Am J Med 1971;51:491-503.
17. Hulley SB, Burrows MI, Wilson WS, Nichaman MZ. Lipid and lipoprotein responses of hypertriglyceridemic outpatients to a low-carbohydrate modification of the A.H.A. fat-controlled diet. Lancet 1972;2:331-5.
18. Hulley S, Ashman P, Kuller L, Lasser N, Sherwin R. HDL-cholesterol levels in the Multiple Risk Factor Intervention Trial (MRFIT). Lipids 1979;14:117-21.
19. Stamler J, Briefel RR, Milas C, Grandits GA, Caggiula AW. Chapter 7. Relation of changes in dietary lipids and weight, trial years 1-6. to changes in blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. In: Stamler J, Caggiula AW, Cutler JA et al, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997;65(suppl):272S-88S.
20. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1:15-9.
21. Carew TE, Koschinsky T, Hayes SB, Steinberg D. A mechanism by which HDL may slow the atherogenic process. Lancet 1976;1:1315-7.
22. Gordon T, Castelli WP, Hjortland MJ, Kannel WB, Dawber TR. HDL as a protective factor against CHD: the Framingham Study. Am J Med 1977;62:707-14.
23. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
24. Stamler J, Neaton JD. Benefits of lower cholesterol. Am Sci Med 1994;1:28-37.
25. Ginsberg H, Olefsky J, Farquhar JW, Reaven GM. Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Ann Intern Med 1974;80:143-9.
26. LaPorte R, Falvo-Gerard L, Kuller L, et al. The relationship between alcohol consumption, liver enzymes and high density lipoprotein cholesterol. Circulation 1981;64(suppl III):67-72.
27. Langer RD, Criqui MH, Reed D. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-5.
28. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986;314: 745-8.
29. Ernst N, Fisher M, Smith W, et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. Circulation 1980;62(suppl IV):41-52.
30. Coulston AM, Liu GC, Reaven GM. Plasma glucose, insulin, and lipid responses to high-carbohydrate low-fat diets in normal humans. Metabolism 1983;32:52-6.
31. Coulston AM, Hollenbeck CB, Swislocki ALM, Chen YI, Reaven GM. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus, Am J Med 1987;82:213-20.
32. Liu GC, Coulston AM, Reaven GM. Effect of high-carbohydrate-low-fat diets on plasma glucose, insulin and lipid responses in hypertriglyceridemic humans. Metabolism 1983;32:750-3.
33. Reaven GM, Looking at the world through LDL-cholesterol-colored glasses. J Nutr 1986;166:1143-7.
34. Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. National Heart, Lung, and Blood Institute report of the Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 1994.
35. People's Republic of China - United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China: baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 1992;85:1083-96.
36. People's Republic of China - United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. Baseline serum lipids (1983-1984). Data preview. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, 1990.
37. Stamler J. Epidemic obesity in the United States. Arch Intern Med 1993;153:1040-4.
38. Popkin BM, Comment: obesity patterns and the nutrition transition in China. Arch Intern Med 1994;154:2249-53.
39. Stamler J. Potential for prevention of major adult cardiovascular diseases. In: Toshima H, Koga Y, Blackburn HJ, Keys A, eds. Lessons for science from the Seven Countries Study: a 35-year collaborative experience in cardiovascular disease epidemiology. Tokyo: Springer-Verlag, 1995:195-235.
40. Lewis B, Katan M, Merkx I, et al. Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet 1981;2: 1310-3.
41. Forbes AC, Bowman BA, eds. Health effects of dietary fructose. Am J Clin Nutr 1993;58(suppl):721S-823S.
42. Nestle M, ed. Mediterranean diets: science and policy implications. Am J Clin Nutr 1995;61(suppl):1313S-427S.
43. National Research Council, Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences. Diet and Health: implications for Reducing Chronic Disease. Washington, DC: National Academy Press, 1989.